These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 30791960)

  • 1. Late-onset megaconial myopathy in mice lacking group I Paks.
    Joseph GA; Hung M; Goel AJ; Hong M; Rieder MK; Beckmann ND; Serasinghe MN; Chipuk JE; Devarakonda PM; Goldhamer DJ; Aldana-Hernandez P; Curtis J; Jacobs RL; Krauss RS
    Skelet Muscle; 2019 Feb; 9(1):5. PubMed ID: 30791960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The p21-activated kinase 2 (PAK2), but not PAK1, regulates contraction-stimulated skeletal muscle glucose transport.
    Møller LLV; Nielsen IL; Knudsen JR; Andersen NR; Jensen TE; Sylow L; Richter EA
    Physiol Rep; 2020 Jun; 8(12):e14460. PubMed ID: 32597567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Group I Paks Promote Skeletal Myoblast Differentiation In Vivo and In Vitro.
    Joseph GA; Lu M; Radu M; Lee JK; Burden SJ; Chernoff J; Krauss RS
    Mol Cell Biol; 2017 Feb; 37(4):. PubMed ID: 27920252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-stimulated glucose uptake partly relies on p21-activated kinase (PAK)2, but not PAK1, in mouse skeletal muscle.
    Møller LLV; Jaurji M; Kjøbsted R; Joseph GA; Madsen AB; Knudsen JR; Lundsgaard AM; Andersen NR; Schjerling P; Jensen TE; Krauss RS; Richter EA; Sylow L
    J Physiol; 2020 Dec; 598(23):5351-5377. PubMed ID: 32844438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential compensation among group I PAK members in hindlimb ischemia and wound healing.
    Elsherif L; Ozler M; Zayed MA; Shen JH; Chernoff J; Faber JE; Parise LV
    PLoS One; 2014; 9(11):e112239. PubMed ID: 25379771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAK1, PAK1Δ15, and PAK2: similarities, differences and mutual interactions.
    Grebeňová D; Holoubek A; Röselová P; Obr A; Brodská B; Kuželová K
    Sci Rep; 2019 Nov; 9(1):17171. PubMed ID: 31748572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional rescue in a mouse model of congenital muscular dystrophy with megaconial myopathy.
    Sayed-Zahid AA; Sher RB; Sukoff Rizzo SJ; Anderson LC; Patenaude KE; Cox GA
    Hum Mol Genet; 2019 Aug; 28(16):2635-2647. PubMed ID: 31216357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1 and PAK2 in cell metabolism regulation.
    Kořánová T; Dvořáček L; Grebeňová D; Röselová P; Obr A; Kuželová K
    J Cell Biochem; 2022 Feb; 123(2):375-389. PubMed ID: 34750857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The subcellular localization of type I p21-activated kinases is controlled by the disordered variable region and polybasic sequences.
    Sun X; Su VL; Calderwood DA
    J Biol Chem; 2019 Sep; 294(39):14319-14332. PubMed ID: 31391252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced mitochondrial fission and impaired energy metabolism in human primary skeletal muscle cells of Megaconial Congenital Muscular Dystrophy.
    Aksu-Menges E; Eylem CC; Nemutlu E; Gizer M; Korkusuz P; Topaloglu H; Talim B; Balci-Hayta B
    Sci Rep; 2021 Sep; 11(1):18161. PubMed ID: 34518586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CHKB mutation expands the megaconial muscular dystrophy phenotype.
    Cabrera-Serrano M; Junckerstorff RC; Atkinson V; Sivadorai P; Allcock RJ; Lamont P; Laing NG
    Muscle Nerve; 2015 Jan; 51(1):140-3. PubMed ID: 25187204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle choline kinase beta defect causes mitochondrial dysfunction and increased mitophagy.
    Mitsuhashi S; Hatakeyama H; Karahashi M; Koumura T; Nonaka I; Hayashi YK; Noguchi S; Sher RB; Nakagawa Y; Manfredi G; Goto Y; Cox GA; Nishino I
    Hum Mol Genet; 2011 Oct; 20(19):3841-51. PubMed ID: 21750112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital megaconial myopathy due to a novel defect in the choline kinase Beta gene.
    Gutiérrez Ríos P; Kalra AA; Wilson JD; Tanji K; Akman HO; Area Gómez E; Schon EA; DiMauro S
    Arch Neurol; 2012 May; 69(5):657-61. PubMed ID: 22782513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p21-Activated protein kinases and their emerging roles in glucose homeostasis.
    Chiang YT; Jin T
    Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E707-22. PubMed ID: 24368667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAK1 and PAK2 have different roles in HGF-induced morphological responses.
    Bright MD; Garner AP; Ridley AJ
    Cell Signal; 2009 Dec; 21(12):1738-47. PubMed ID: 19628037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rostrocaudal muscular dystrophy caused by a defect in choline kinase beta, the first enzyme in phosphatidylcholine biosynthesis.
    Sher RB; Aoyama C; Huebsch KA; Ji S; Kerner J; Yang Y; Frankel WN; Hoppel CL; Wood PA; Vance DE; Cox GA
    J Biol Chem; 2006 Feb; 281(8):4938-48. PubMed ID: 16371353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Megaconial muscular dystrophy caused by mitochondrial membrane homeostasis defect, new insights from skeletal and heart muscle analyses.
    Vanlander AV; Muiño Mosquera L; Panzer J; Deconinck T; Smet J; Seneca S; Van Dorpe J; Ferdinande L; Ceuterick-de Groote C; De Jonghe P; Van Coster R; Baets J
    Mitochondrion; 2016 Mar; 27():32-8. PubMed ID: 26855408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group I p21-activated kinases regulate thyroid cancer cell migration and are overexpressed and activated in thyroid cancer invasion.
    McCarty SK; Saji M; Zhang X; Jarjoura D; Fusco A; Vasko VV; Ringel MD
    Endocr Relat Cancer; 2010 Dec; 17(4):989-99. PubMed ID: 20817787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAK1 inhibition reduces tumor size and extends the lifespan of mice in a genetically engineered mouse model of Neurofibromatosis Type 2 (NF2).
    Hawley E; Gehlhausen J; Karchugina S; Chow HY; Araiza-Olivera D; Radu M; Smith A; Burks C; Jiang L; Li X; Bessler W; Masters A; Edwards D; Burgin C; Jones D; Yates C; Clapp DW; Chernoff J; Park SJ
    Hum Mol Genet; 2021 Aug; 30(17):1607-1617. PubMed ID: 34075397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.